buformin has been researched along with Liver Cirrhosis in 1 studies
Buformin: An oral hypoglycemic agent that inhibits gluconeogenesis, increases glycolysis, and decreases glucose oxidation.
buformin : A member of the class of biguanides that is biguanide substituted by a butyl group at position 1. It is an antidiabetic drug with potential antitumor effect.
Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buess, HJ | 1 |
| Mihatsch, MJ | 1 |
| Wunderlich, P | 1 |
| Berger, W | 1 |
1 other study available for buformin and Liver Cirrhosis
| Article | Year |
|---|---|
[Lactic acidosis in diabetes mellitus (author's transl)].
Topics: Acidosis; Aged; Alcoholism; Buformin; Diabetes Complications; Female; Heart Failure; Humans; Hyperte | 1976 |